Experimental studies have identified a complex link between neurodegeneration, β-amyloid (Aβ) and calcium homeostasis. Here we asked whether early phase β-amyloid pathology in transgenic hAPPSL mice exaggerates the ischemic lesion and remote secondary pathology in the thalamus, and whether a non-selective calcium channel blocker reduces these pathologies. Transgenic hAPPSL (n = 33) and non-transgenic (n = 30) male mice (4–5 months) were subjected to unilateral cortical photothrombosis and treated with the non-selective calcium channel blocker bepridil (50 mg/kg, p.o., once a day) or vehicle for 28 days, starting administration 2 days after the operation. Animals were then perfused for histological analysis of infarct size, Aβ and calcium accumulation in the thalamus. Cortical photothrombosis resulted in a small infarct, which was associated with atypical Aβ and calcium accumulation in the ipsilateral thalamus. Transgenic mice had significantly smaller infarct volumes than non-transgenic littermates (P<0.05) and ischemia-induced rodent Aβ accumulation in the thalamus was lower in transgenic mice compared to non-transgenic mice (P<0.01). Bepridil decreased calcium load in the thalamus (P<0.01). The present data suggest less pronounced primary and secondary pathology in hAPPSL transgenic mice after ischemic cortical injury. Bepridil particularly decreased calcium pathology in the thalamus following ischemia.
References
[1]
Fernando MS, Ince PG (2004) Vascular pathologies and cognition in a population-based cohort of elderly people. Journal of the Neurological Sciences 226: 13–17.
[2]
Schneider JA, Arvanitakis Z, Bang W, Bennett DA (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69: 2197–2204.
[3]
Peers C, Pearson HA, Boyle JP (2007) Hypoxia and Alzheimer's disease. Essays in Biochemistry 43: 153–164.
[4]
Abe K, Tanzi RE, Kogure K (1991) Selective induction of kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neuroscience Letters 125: 172–174.
[5]
Badan I, Dinca I, Buchhold B, Suofu Y, Walker L, et al. (2004) Accelerated accumulation of N- and C-terminal beta APP fragments and delayed recovery of microtubule-associated protein 1B expression following stroke in aged rats. The European Journal of Neuroscience 19: 2270–2280.
[6]
Koistinaho J, Pyykonen I, Keinanen R, Hokfelt T (1996) Expression of beta-amyloid precursor protein mRNAs following transient focal ischaemia. Neuroreport 7: 2727–2731.
[7]
Shi J, Yang SH, Stubley L, Day AL, Simpkins JW (2000) Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Research 853: 1–4.
[8]
Koistinaho M, Koistinaho J (2005) Interactions between Alzheimer's disease and cerebral ischemia-focus on inflammation. Brain Research Reviews 48: 240–250.
[9]
Lipsanen A, Hiltunen M, Jolkkonen J (2011) Chronic ibuprofen treatment does not affect the secondary pathology in the thalamus or improve behavioral outcome in middle cerebral artery occlusion rats. Pharmacology, Biochemistry and Behavior 99: 468–474.
[10]
Zhang F, Eckman C, Younkin S, Hsiao KK, Iadecola C (1997) Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. The Journal of Neuroscience 17: 7655–7661.
[11]
Koistinaho M, Kettunen MI, Goldsteins G, Kein？nen R, Salminen A, et al. (2002) Β-amyloid precursor protein transgenic mice that harbor diffuse Aβ deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation. Proceedings of the National Academy of Sciences 99: 1610–1615.
[12]
Whitehead SN, Hachinski VC, Cechetto DF (2005) Interaction between a rat model of cerebral ischemia and beta-amyloid toxicity: Inflammatory responses. Stroke 36: 107–112.
[13]
Whitehead SN, Massoni E, Cheng G, Hachinski VC, Cimino M, et al. (2010) Triflusal reduces cerebral ischemia induced inflammation in a combined mouse model of alzheimer's disease and stroke. Brain Research 1366: 246–56.
[14]
Whitehead SN, Cheng G, Hachinski VC, Cechetto DF (2007) Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid. Stroke 38: 3245–50.
[15]
van Groen T, Puurunen K, M？ki HM, Sivenius J, Jolkkonen J (2005) Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats. Stroke 36: 1551–1556.
[16]
Hiltunen M, M？kinen P, Per？niemi S, Sivenius J, van Groen T, et al. (2009) Focal cerebral ischemia in rats alters APP processing and expression of abeta peptide degrading enzymes in the thalamus. Neurobiology of Disease 35: 103–113.
[17]
M？kinen S, van Groen T, Clarke J, Thornell A, Corbett D, et al. (2008) Coaccumulation of calcium and beta-amyloid in the thalamus after transient middle cerebral artery occlusion in rats. Journal of Cerebral Blood Flow and Metabolism 28: 263–268.
[18]
Hiltunen M, Jolkkonen J (2011) Complex pathology in the thalamus following cerebral ischemia. In: Song JL, editor. Thalamus: Anatomy, Functions and Disorders. Nova Science Publishers, Inc. pp. 83–98.
[19]
Saraj？rvi T, Lipsanen A, M？kinen P, Per？niemi S, Soininen H, et al. (2012) Bepridil decreases abeta and calcium levels in the thalamus after middle cerebral artery occlusion in rats. Journal of Cellular and Molecular Medicine 16: 2754–2767.
[20]
Demuro A, Parker I, Stutzmann GE (2010) Calcium signaling and amyloid toxicity in alzheimer disease. The Journal of Biological Chemistry 285: 12463–12468.
[21]
Riascos D, de Leon D, Baker-Nigh A, Nicholas A, Yukhananov R, et al. (2011) Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer's disease. Acta Neuropathologica 122: 565–576.
[22]
Supnet C, Bezprozvanny I (2010) The dysregulation of intracellular calcium in Alzheimer disease. Cell Calcium 47: 183–189.
[23]
Havas D, Hutter-Paier B, Ubhi K, Rockenstein E, Crailsheim K, et al. (2011) A longitudinal study of behavioral deficits in an AbetaPP transgenic mouse model of Alzheimer's disease. Journal of Alzheimer's Disease 25: 231–243.
[24]
Huttunen HJ, Havas D, Peach C, Barren C, Duller S, et al. (2010) The acyl-coenzyme A: cholesterol acyltransferase inhibitor CI-1011 reverses diffuse brain amyloid pathology in aged amyloid precursor protein transgenic mice. Journal of Neuropathology & Experimental Neurology 69: 777–88.
[25]
Paylor R, Nguyen M, Crawley JN, Patrick J, Beaudet A, et al. (1998) Α7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: A behavioral characterization of acra7-deficient mice. Learning & Memory 5: 302–316.
[26]
Deschênes M, Veinante P, Zhang Z (1998) The organization of corticothalamic projections: Reciprocity versus parity. Brain Research Reviews 28: 286–308.
[27]
Yankner BA, Lu T (2009) Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease. Journal of Biological Chememistry 284: 4755–9.
[28]
Clarke J, Thornell A, Corbett D, Soininen H, Hiltunen M, et al. (2007) Overexpression of APP provides neuroprotection in the absence of functional benefit following middle cerebral artery occlusion in rats. The European Journal of Neuroscience 26: 1845–1852.
[29]
Stein TD, Anders NJ, DeCarli C, Chan SL, Mattson MP, et al. (2004) Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. Journal of Neuroscience 24: 7707–7717.
[30]
Han P, Dou F, Li F, Zhang X, Zhang YW, et al. (2005) Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation. Journal of Neuroscience 25: 11542–11552.
[31]
Gralle M, Botelho MG, Wouters FS (2009) Neuroprotective secreted amyloid precursor protein acts by disrupting amyloid precursor protein dimers. Journal of Biological Chemistry 284: 15016–15025.
[32]
Smith-Swintosky VL, Pettigrew LC, Craddock SD, Culwell AR, Rydel RE, et al. (1994) Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. Journal of Neurochemistry 63: 781–4.
[33]
Thornton E, Vink R, Blumbergs PC, Van Den Heuvel C (2006) Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Research 1094: 38–46.
[34]
Corrigan F, Pham CL, Vink R, Blumbergs PC, Masters CL, et al. (2011) The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains. Brain Research 1378: 137–143.
[35]
Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, et al. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 10: 243–254.
[36]
K？gel D, Deller T, Behl C (2012) Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging. Experimental Brain Research 217(3–4): 471–9.
[37]
Ross DT, Ebner FF (1990) Thalamic retrograde degeneration following cortical injury: an excitotoxic process? Neuroscience 35: 525–50.
[38]
Zhang J, Zhang Y, Li J, Xing S, Li C, Li Y, et al. (2012) Autophagosomes accumulation is associated with β-amyloid deposits and secondary damage in the thalamus after focal cortical infarction in hypertensive rats. Journal of Neurochemistry 120: 564–73.
[39]
Yu WH, Kumar A, Peterhoff C, Shapiro Kulnane L, et al. (2004) Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease. International Journal of Biochemistry and Cell Biology 36: 2531–40.
[40]
Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, et al. (2006) Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proceedings of the National Academy of Sciences of the United States of America 103: 11172–7.
[41]
Aho L, Jolkkonen J, Alafuzoff I (2006) Beta-amyloid aggregation in human brains with cerebrovascular lesions. Stroke 37: 2940–2945.
[42]
Watanabe H, Kumon Y, Ohta S, Sakaki S, Matsuda S, et al. (1998) Changes in protein synthesis and calcium homeostasis in the thalamus of spontaneously hypertensive rats with focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 18: 686–96.
[43]
Chen X, Li M, Chen D, Gao W, Guan JL, et al. (2012) Autophagy induced by calcium phosphate precipitates involves endoplasmic reticulum membranes in autophagosome biogenesis. PLoS One 7: e52347.
[44]
Stys PK, LoPachin RM (1997) Mechanisms of calcium and sodium fluxes in anoxic myelinated central nervous system axons. Neuroscience 82: 21–32.
